We think of dementia as the overarching destruction of the brain resulting in an inability to perform daily tasks or interact appropriately, but that’s not always the case.
After yielding promising results in a clinical trial, an LSD formulation aimed at treating generalized anxiety disorder has been awarded Breakthrough Therapy status by the U.S. Food and Drug Administration.
It’s open season for killers with automatic assault weapons who, in too many instances, don’t require a license, a background check, or even be older than 18.